diabetes

Stories 181 - 195 | << Prev 

In Vino ... a Fountain of Youth?
In Vino ...
a Fountain
of Youth?
Aug 30, 2007 5:46 AM CDT

In Vino ... a Fountain of Youth?

Harvard man finds red wine chemical helps mice live 24% longer

(Newser) - A Harvard scientist armed with great salesmanship and optimism has isolated a red wine ingredient he says will make humans live longer and healthier. Resveratrol may be the chemical at rainbow’s end in the quest to activate the SIRT1 gene, Technology Review reports; David Sinclair has shushed some doubters...

We're Still Getting Fatter
We're Still Getting Fatter
Aug 27, 2007 6:07 PM CDT

We're Still Getting Fatter

Obesity epidemic continues to spread

(Newser) - Americans just keep getting fatter. Obesity rates were up in 31 states this year and declined in none, a new study by a health advocacy group finds. That brings the percentage of American adults who are either obese or overweight to 60%, Reuters reports, and the usual suspects are to...

Weight-Loss Surgery Can End Diabetes
Weight-Loss Surgery Can
End Diabetes
Aug 22, 2007 10:52 AM CDT

Weight-Loss Surgery Can End Diabetes

Intestinal rerouting works miracles, but science still debated

(Newser) - Surgery that shrinks stomachs and reroutes intestines can make diabetes disappear—but some worry the procedure is the wrong one for the disease. More than three of four diabetics who undergo bariatric surgery are left with no symptoms, and can even live without insulin. But docs are concerned about complications...

New Procedure Gives Hope to Diabetics

UK treatment ends insulin dependency for type 1 sufferers

(Newser) - Car crashes, comas, sudden stabbings, divorces – all are being indirectly diminished as Britain spearheads a new procedure to help sufferers of type 1 diabetes. Victims of the growing disorder are often subject to fits and blackouts as they scramble for insulin, but a new operation is offering hope: already...

Bone Hormone Could Help Treat Diabetes

Bones produce a hormone that controls blood sugar

(Newser) - A substance produced by the skeleton may help to treat diabetes, a new study suggests. A hormone called osteocalcin regulates blood sugar; type 2 diabetics have a lower level of the hormone than other people. In the study, mice with lower levels of osteocalcin develop symptoms of diabetes, which go...

FDA Panel Votes to Keep Avandia on Shelves

Controversial diabetes drug still faces heart-attack link

(Newser) - An FDA panel said today that GlaxoSmithKline's diabetes drug Avandia should remain in drugstores, despite earlier evidence the pill ups heart failure risks. Glaxo has defended its drug, countering that the risks associated with the popular Avandia are the same as those of other diabetes drugs.

Coffee's Perks Not in the Caffeine
Coffee's Perks Not in the Caffeine
Jun 25, 2007 3:59 AM CDT

Coffee's Perks Not in the Caffeine

Go for decaf: other chemicals in coffee give health a jolt

(Newser) - Scientists have long championed coffee's health benefits, but a series of recent studies is waking them up to the fact that caffeine has nothing to do with it. Regular consumption of coffee or tea can provide protection against cancer, diabetes and heart disease, but researchers say other chemicals are responsible.

Genes Give Up Secrets of 7 Serious Diseases

Landmark study sheds light on diabetes, depression, more

(Newser) - In an outcome one scientist describes as a "new dawn," researchers have identified genetic variations linked to seven common diseases, opening the door to improved tests and treatments. The study, which focused on depression, Crohn's disease, coronary artery disease, hypertension, rheumatoid arthritis, and Type 1 and 2 diabetes,...

Controversy Rages Over Diabetes Drug's Heart Risks

FDA official says superiors ordered her to back off serious warning

(Newser) - Troubling questions about the diabetes drug Avandia persisted yesterday as an FDA official revealed that she was barred from recommending a critical warning about the medication, the Times reports. In the run-up to congressional hearings that began today, manufacturer GlaxoSmithKline rushed to disseminate interim clinical findings in hopes of blunting...

Glaxo Stems Stock Slide Over Avandia

Medical chief rebuts findings on heart risks; claims comparable to other drugs

(Newser) - Glaxo shares pulled out of a tailspin after the pharma giant defended its second biggest selling drug, Avandia, against claims that it triggers heart attacks.  A sharply worded letter from the company's chief medical officer on the website of medical journal The Lancet pointed out that the increased incidence...

FDA Warned of Avandia Risks Years Ago

Doctor alerted agency to cardiovascular concerns in 2000

(Newser) - A diabetes doctor warned the FDA of heart risks posed by the diabetes drug Avandia seven years ago, the New York Times reports. The same concerns raised by Dr. John Buse in a 2000 letter were reiterated in a study published by cardiologist Steven Nissen this week.

Drug Company Nemesis Strikes Again
Drug Company Nemesis
Strikes Again
May 22, 2007 1:32 PM CDT

Drug Company Nemesis Strikes Again

Crusading cardiologist took on Vioxx, now Avandia, for heart risks

(Newser) - The doctor who helped to raise concerns about the painkiller Vioxx is back—with the study released earlier this week linking the same company's popular diabetes drug, Avandia, to higher risk of heart attacks. The Wall Street Journal looks at 58-year-old cardiologist Steven Nissen's role in identifying and publicizing drug...

Diabetes Drug Ups Heart Risk
Diabetes
Drug Ups
Heart Risk
May 21, 2007 3:15 PM CDT

Diabetes Drug Ups Heart Risk

New study documents dangers of Avandia, but company nixes recall

(Newser) - A popular diabetes drug may increase heart attack risks, a study reported in the New England Journal of Medicine concludes. Patients who took Avandia, which treats Type 2 diabetes, were 43% more likely to have a heart attack than those who took a placebo, the Cleveland Clinic study found.

Researchers Fight Fat With Baby Formula

Introducing hormone in infancy trims down rats, sparks controversy

(Newser) - The battle to keep pounds off may start with a baby bottle, say a team of British scientists who found that feeding large doses of the appetite-controlling hormone leptin to baby rats led to svelte adult rats. If those results translate to humans, a baby formula that chemically alters metabolism...

Insurer Ties Employee Pay to Patient Health

Plan will offer bonuses for boosting patients' use of preventive services

(Newser) - The country's largest health insurer says it will pay up for good health--offering bonuses to employees who boost patients' use of preventive medical services. WellPoint Inc.'s plan is intended to encourage participation in programs like diabetes management, which helps patients handle their medical needs before they end up in...

Stories 181 - 195 | << Prev